Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BRUN

Showing results (221-230 of 298) with videos related to

Pageof 30
Sort By:
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
The Journal of Antimicrobial Chemotherapy|September 14, 2014
MLST reveals potentially high-risk international clones of Enterobacter cloacaeR Izdebski, A Baraniak, M Herda, et al.
Stroke|February 10, 2007
Determinants of intracerebral hemorrhage growth: an exploratory analysisJoseph P Broderick, Michael N Diringer, Michael D Hill, et al.
Annals of Internal Medicine|September 12, 1998
Incidence of and risk factors for ventilator-associated pneumonia in critically ill patientsD J Cook, S D Walter, R J Cook, et al.
Acta Medica Scandinavica|January 1, 1982
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritisH Thysell, P Bygren, U Bengtsson, et al.
Human Brain Mapping|December 10, 2009
3D mapping of brain differences in native signing congenitally and prelingually deaf subjectsNatasha Leporé, Patrick Vachon, Franco Lepore, et al.
Pageof 30

Showing results (221-230 of 298) with videos related to

Sort By:
Pageof 30
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
The Journal of Antimicrobial Chemotherapy|September 14, 2014
MLST reveals potentially high-risk international clones of Enterobacter cloacaeR Izdebski, A Baraniak, M Herda, et al.
Stroke|February 10, 2007
Determinants of intracerebral hemorrhage growth: an exploratory analysisJoseph P Broderick, Michael N Diringer, Michael D Hill, et al.
Annals of Internal Medicine|September 12, 1998
Incidence of and risk factors for ventilator-associated pneumonia in critically ill patientsD J Cook, S D Walter, R J Cook, et al.
Acta Medica Scandinavica|January 1, 1982
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritisH Thysell, P Bygren, U Bengtsson, et al.
Human Brain Mapping|December 10, 2009
3D mapping of brain differences in native signing congenitally and prelingually deaf subjectsNatasha Leporé, Patrick Vachon, Franco Lepore, et al.
Pageof 30